Terms: = Brain cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
5 results:
1. Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
Grob ST; Miller KR; Sanford B; Donson AM; Jones K; Griesinger AM; Amani V; Foreman NK; Liu A; Handler M; Hankinson TC; Milgrom S; Levy JMM
J Neurooncol; 2023 Oct; 165(1):161-169. PubMed ID: 37878192
[TBL] [Abstract] [Full Text] [Related]
2. Incidental findings on 3 T neuroimaging: cross-sectional observations from the population-based Rhineland Study.
Lohner V; Lu R; Enkirch SJ; Stöcker T; Hattingen E; Breteler MMB
Neuroradiology; 2022 Mar; 64(3):503-512. PubMed ID: 34842946
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
[TBL] [Abstract] [Full Text] [Related]
4. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of care and survival outcomes in patients with astroblastoma: an individual patient data analysis of 152 cases.
Mallick S; Benson R; Venkatesulu B; Melgandi W; Rath GK
Childs Nerv Syst; 2017 Aug; 33(8):1295-1302. PubMed ID: 28477040
[TBL] [Abstract] [Full Text] [Related]
